ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 061,35
-0,03%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bio Rad Laboratories Inc (BIO)

  7. Bio Rad Laboratories Inc (BIO) Actualités

BIO

Bio Rad Laboratories (BIO)

Bio Rad Laboratories Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BIO
DateHeureSourceTitreSymboleSociété
09/05/202422h30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:BIOBio Rad Laboratories Inc
08/05/202422h38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BIOBio Rad Laboratories Inc
08/05/202422h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIOBio Rad Laboratories Inc
08/05/202420h25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BIOBio Rad Laboratories Inc
07/05/202422h18Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIOBio Rad Laboratories Inc
07/05/202422h15Business WireBio-Rad Reports First-Quarter 2024 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
01/05/202415h00Business WireBio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
26/04/202414h30Business WireBio-Rad Announces Life Science Group Management ChangesNYSE:BIOBio Rad Laboratories Inc
18/04/202415h00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIOBio Rad Laboratories Inc
11/04/202423h30GlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNYSE:BIOBio Rad Laboratories Inc
10/04/202422h15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIOBio Rad Laboratories Inc
20/03/202413h30Business WireBio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial OfficerNYSE:BIOBio Rad Laboratories Inc
22/02/202422h30Business WireBio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access DayNYSE:BIOBio Rad Laboratories Inc
15/02/202422h15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
24/01/202423h00Business WireBio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024NYSE:BIOBio Rad Laboratories Inc
02/01/202422h15Business WireBio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
26/10/202322h15Business WireBio-Rad Reports Third-Quarter 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
05/10/202314h30Business WireBio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023NYSE:BIOBio Rad Laboratories Inc
28/08/202322h15Business WireBio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
03/08/202322h15Business WireBio-Rad Reports Second-Quarter 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
26/07/202322h15Business WireBio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing AgreementNYSE:BIOBio Rad Laboratories Inc
20/07/202322h30Business WireBio-Rad Announces New Share Repurchase ProgramNYSE:BIOBio Rad Laboratories Inc
10/07/202322h30Business WireBio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023NYSE:BIOBio Rad Laboratories Inc
10/07/202315h00Business WireBio-Rad Publishes Corporate Sustainability Report for 2022NYSE:BIOBio Rad Laboratories Inc
15/06/202323h13Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:BIOBio Rad Laboratories Inc
07/06/202317h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BIOBio Rad Laboratories Inc
05/06/202314h46Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BIOBio Rad Laboratories Inc
01/06/202314h00Business WireBio-Rad to Present Company Overview at Jefferies Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
24/05/202322h51Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:BIOBio Rad Laboratories Inc
08/05/202314h00Business WireBio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
 Showing the most relevant articles for your search:NYSE:BIO

Dernières Valeurs Consultées

ASE
BOC
EU
VIO
Viohalco
LSE
AAC
EU
CARM
Carrefour Property Devel...
BOV
BRKM6Q
BRASKEM PNB
TSX
XEI
iShares S&P TSX Composit...
EU
5837T
5837T
EU
CLARI
Clariane
BOV
BHIA12
Grupo Casas Bahia ON
BOV
EMBR3R
EMBRAER ON
NYSE
SO
Southern
NYSE
AAC
Ares Acquisition
EU
U229S
U229S
TSXV
VLV
Venerable Ventures
BOV
EMBR3
EMBRAER ON
EU
4417S
4417S
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés